Navigation Links
Global Biosimilars Market - Products, Applications and Regulations
Date:3/15/2013

DUBLIN, March 15, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Biosimilars Market - Products, Applications and Regulations" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Off-Patent Biologics to Boost the Growth of Biosimilars Global Market to Reach US$19.4bn by 2018

Several of the leading 25 manufacturers of biosimilars have been entrenched in the market, and have the experience of marketing products for the last 5-10 years. On the other hand, several companies' position is expected to be challenged over the next ten years, since the rapid growth forecast for the biosimilars market has attracted several new companies to enter this lucrative arena. Current leaders, in order to maintain market share, need to introduce new biosimilars over the next few years with a specific focus on the products in demand. Licensing deals are expected to expand the pipelines of established players, as well as new market entrants.

The global biosimilar market, estimated at US$2 billion in 2012 and expected to touch US$2.7 billion in 2013, is further projected to reach US$19.4 billion by 2018, exhibiting a CAGR of 36.6% over 2009-2018. This growth can be attributed to some of the top-selling biologics coming off-patent over the coming few years and biosimilar manufacturers are bound to make a beeline towards this lucrative opportunity.

Publication Overview

This report reviews, analyzes and projects the biosimilars market for global and regional markets including the United States, Europe, Asia-Pacific and Rest of World. The market numbers illustrated in this report only represent the market exclusively for the product segments and application areas enunciated above. The regional markets further analyzed for 8 more independent countries across Europe - France, Germany, Italy, Spain, the United Kingdom and Rest of Europe; Asia-Pacific - China, India, South Korea and Rest of Asia-Pacific.

The market for application areas of biosimilars analyzed in this study includes Blood Disorders, Chronic Diseases, Growth Hormone Deficiency, Oncology and Others. The report also encompasses the market analysis for product segments - Monoclonal Antibodies, Erythropoietin, Human Growth Hormone, Insulin, G-CSF, Interferons and Others.

This 354 page global market report includes 149 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of the market. The statistical tables represent the data for the global market by geographic region, application area and product segment.The report covers the brief business profiles of 43 key global players and 54 major players across the United States - 13; Europe - 18; Asia-Pacific - 19 and Rest of World - 4. The report also provides the listing of the companies engaged in research and development, manufacturing, processing, supplies and distribution of biosimilars. Also enlisting the academic institutions and industry associations engaged in biosimilars, the global list covers the addresses, contact numbers and the website addresses of 168 companies.

Key Topics Covered: 
Part A: Global Market Perspective

1. Introduction
2. Biosimilar Applications - A Snapshot
3. Regulatory Landscape
4. Key Market Trends
5. Key Global Players
6. Key Business Trends
7. Global Market Overview

Part B: Regional Market Perspective

Regional Market Overview

1. The United States
2. Europe
3. Asia-Pacific
4. Rest Of World

Part C: Guide To The Industry

1. North America
2. Europe
3. Asia-Pacific
4. Rest Of World

Part D: Annexure
1. Research Methodology
2. The Questionnaire
3. Feedback
Charts & Graphs
Examples of Companies Mentioned

- 3SBio
- Amgen
- Astrazeneca
- Baxter International
- Biocon
- Biogen IDEC
- Bioton
- Cadila Healthcare
- Celltrion
- Daiichi Sankyo Company
- DSM Biologics
- GE Healthcare
- Glaxosmithkline
- iBio
- Merck
- Mitsubishi Tanabe Pharma Corporation
- Mylan
- Novartis
- Perkinelmer
- Pfizer Inc
- Roche Holding
- Samsung Biologics
- Sandoz International
- Sanofi
- Shantha Biotechnics
- Watson Pharmaceuticals
- Wockhardt Limited


For more information visit http://www.researchandmarkets.com/research/xn2btj/global

Research and Markets
Laura Wood , Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Probiotics Industry
2. Global Blood Processing Supplies And Equipment Industry
3. Thoratec Presentation At Barclays Global Healthcare Conference To Be Webcast
4. Perrigo Company To Present At The Barclays Global Healthcare Conference
5. Tucson Symposium attracts over 450 global scientists focused on personalized healthcare
6. Janssen Launches EXPLORER, Global Cardiovascular Research Program, Beginning with Five New Studies in Patients with Unmet Medical Needs
7. Global Insulin Antidiabetics Market 2012-2016
8. In Vitro Diagnostics Markets Grow at Double the Pace of Pharma Markets in Shift toward Globalization
9. For International Life Sciences, Biotech and Pharmaceutical Events, Top Executives Turn to Global Information
10. HeartWare Presentation at the Barclays Capital 2013 Global Healthcare Conference To Be Webcast
11. Isis Pharmaceuticals to Present at the Barclays Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... One of Australia,s successful biotechnology scientists, Dr ... biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm ... on the ASX. Noxopharm is a clinic-ready company with ... 1 clinical study later this year. ... problems facing cancer patients - the ability of cancers to become ...
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology:
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, ... stem (iPS) cells and other difficult to transfect cells, announces its launch of ... PluriQ™ G9™ Gene Editing System is a complete system for culturing and ...
Breaking Medicine News(10 mins):